[1] Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, Cowell JK, Dalmau J. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels:a case series[J]. Lancet Neurol, 2010, 9:776-785.
[2] Ohkawa T, Fukata Y, Yamasaki M, Miyazaki T, Yokoi N, Takashima H, Watanabe M, Watanabe O, Fukata M. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors[J]. J Neurosci, 2013, 33:18161-18174.
[3] Mir A, Thani Z, Bashir S, Ayed H, Albaradie R. LGI-1 antibody encephalitis in a seven-year-old girl[J]. Epileptic Disord, 2019, 21:591-597.
[4] Song JM, Sheng AZ, Zeng XY, Gong T, Chen YH. A case report of leucine rich glioma inactivated 1-antibody encephalitis with autonomic dysfunction[J]. Zhonghua Shen Jing Ke Za Zhi, 2020, 53:364-367[.宋江曼, 盛爱珍, 曾湘豫, 龚涛, 陈玉辉. 以自主神经功能异常为首发症状的富亮氨酸胶质瘤失活1蛋白抗体相关脑炎一例[J]. 中华神经科杂志, 2020, 53:364-367.]
[5] Whiles E, Joshi H, Prachi P, Kavuri V, Sagi SV. Leucine-rich glioma-inactivated protein 1(LGI-1) mediated limbic encephalitis associated with syndrome of inappropriate antidiuretic hormone secretion:a case report[J]. Oxf Med Case Reports, 2020:omz136.
[6] Li LH, Ma CC, Zhang HF, Lian YJ. Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis[J]. Epilepsy Behav, 2018, 88:277-282.
[7] Li Y, Song F, Liu W, Wang Y. Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis[J]. Acta Neurol Belg, 2020[.Epub ahead of print]
[8] Lv RJ, Sun ZR, Cui T, Guan HZ, Ren HT, Shao XQ. Temporal lobe epilepsy with amygdala enlargement:a subtype of temporal lobe epilepsy[J]. BMC Neurol, 2014, 14:194.
[9] Flanagan EP, Kotsenas AL, Britton JW, McKeon A, Watson RE, Klein CJ, Boeve BF, Lowe V, Ahlskog JE, Shin C, Boes CJ, Crum BA, Laughlin RS, Pittock SJ. Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures[J]. Neurol Neuroimmunol Neuroinflamm, 2015, 2:e161.
[10] Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ. Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients[J]. Ann Neurol, 2017, 82:79-92.
[11] Liu X, Shan W, Zhao X, Ren J, Ren G, Chen C, Shi W, Lv R, Li Z, Liu Y, Ai L, Wang Q. The clinical value of 18F-FDG-PET in autoimmune encephalitis associated with LGI1 antibody[J]. Front Neurol, 2020, 11:418.
[12] Shan W, Liu X, Wang Q. Teaching NeuroImages:18F-FDG-PET/SPM analysis in 3 different stages from a patient with LGI-1 autoimmune encephalitis[J]. Neurology, 2019, 93:e1917-1918.
[13] Sánchez-Ordúz L, Gállego Pérez-Larraya J, Grisanti F, Centeno M, Arbizu J. Caspr2 antibody-associated limbic encephalitis:contribution of visual aided analysis of 18F-FDG PET images using normal database comparison[J]. Rev Esp Med Nucl Imagen Mol (Engl Ed), 2020, 39:92-95.
[14] Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR; Faciobrachial Dystonic Seizures Study Group. The importance of early immunotherapy in patients with faciobrachial dystonic seizures[J]. Brain, 2018, 141:348-356.
[15] Neurology Branch, Chinese Medical Association. Expert consensus on diagnosis and treatment of autoimmune encephalitis in China[J]. Zhonghua Shen Jing Ke Za Zhi, 2017, 50:91-98[.中华医学会神经病学分会. 中国自身免疫性脑炎诊治专家共识[J]. 中华神经科杂志, 2017, 50:91-98.]
[16] Shin YW, Lee ST, Shin JW, Moon J, Lim JA, Byun JI, Kim TJ, Lee KJ, Kim YS, Park KI, Jung KH, Lee SK, Chu K. VGKC-complex/LGI1-antibody encephalitis:clinical manifestations and response to immunotherapy[J]. J Neuroimmunol, 2013, 265:75-81.
[17] Ghimire P, Khanal UP, Gajurel BP, Karn R, Rajbhandari R, Paudel S, Gautam N, Ojha R. Anti-LGI1, anti-GABABR, and anti-CASPR2 encephalitides in Asia:a systematic review[J]. Brain Behav, 2020, 10:e01793.
[18] Ge XY, Yang HN, Jia GY, Wang CL. Clinical analysis of 17 cases of LGI1 limbic encephalitis[J]. Zhongguo Shen Jing Jing Shen Ji Bing Za Zhi, 2018, 44:201-205[.葛晓燕, 杨洪娜, 贾国勇, 王翠兰. 抗LGI1抗体相关边缘性脑炎17例临床分析[J]. 中国神经精神疾病杂志, 2018, 44:201-205.]
[19] Szots M, Marton A, Kover F, Kiss T, Berki T, Nagy F, Illes Z. Natural course of LGI1 encephalitis:3-5 years of follow-up without immunotherapy[J]. J Neurol Sci, 2014, 343:198-202.
[20] Celicanin M, Blaabjerg M, Maersk-Moller C, Beniczky S, Marner L, Thomsen C, Bach FW, Kondziella D, Andersen H, Somnier F, Illes Z, Pinborg LH. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies-a national cohort study[J]. Eur J Neurol, 2017, 24:999-1005. |